Change Agents Corp. Lands $10M Equity Line with Hudson Global Ventures, Attaches 925K Penny Warrants
Summary
Change Agents Corporation entered a $10M equity line with Hudson Global Ventures, issuing 925,925 warrants at a $0.01 exercise price. The deal provides a cash runway but introduces severe dilution risk and a $250K cash penalty if stockholder approval is delayed.
Key Events · Financing and Capital Events · ALBT
-
$10M Equity Line Established
The company may sell up to $10M of common stock to Hudson Global Ventures at a fixed $0.30 per share — a premium to the current $0.28 price — over a 36-month period.
-
925,925 Penny Warrants Issued
As part of the deal, the investor received warrants to purchase 925,925 shares at $0.01 each, exercisable upon stockholder approval. At current prices, this represents immediate deep-in-the-money dilution.
-
$250K Cash Penalty Risk
If stockholder approval for the warrant shares is not obtained within 75 days, the company must pay $250,000 in cash — a material sum for a company already under a going concern warning.
-
True-Up Payment Mechanism
Even if stockholder approval is secured, a true-up clause kicks in: should the 5-day average price before approval fall below $0.27, the company must pay the difference between $250,000 and the warrant value, further straining its cash position.
Analysis · ALBT · Technology
Already carrying a going concern warning and a history of dilutive deals, Change Agents Corporation has now secured a $10 million equity line from Hudson Global Ventures. The agreement lets the company sell shares at a fixed $0.30 — a modest premium to the current $0.28 price — but the real sting lies in the 925,925 warrants exercisable at just $0.01 apiece, which could unleash massive dilution. Should stockholder approval for those warrants fail to materialize within 75 days, the company must fork over $250,000 in cash, a punishing sum given its fragile finances. The structure bears all the hallmarks of high-risk, death-spiral financing: the investor pockets deeply discounted warrants while the company buys a lifeline at a steep cost to existing shareholders.
At the time of this filing, ALBT was trading at $0.28 on NASDAQ in the Technology sector, with a market capitalization of approximately $4.1M. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.